Status:
COMPLETED
Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Breast Cancer
Eligibility:
All Genders
35-64 years
Brief Summary
This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive ...
Detailed Description
The purpose of the women's CARE study was a population based case control study designed to evaluate risk factors for breast cancer among white and African American women ages 35-64 in the United Stat...
Eligibility Criteria
Inclusion
- Original recruitment were cases identified by the Surveillance, Epidemiology and End Results (SEER) cancer registry several years ago for the data set. Accrual is now completed.
Exclusion
Key Trial Info
Start Date :
January 18 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 24 2015
Estimated Enrollment :
9257 Patients enrolled
Trial Details
Trial ID
NCT00341159
Start Date
January 18 2005
End Date
February 24 2015
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892